Corydalis Yanhusuo + Erdafitinib
Erdafitinib brand name: Balversa.
Erdafitinib falls into 2 drug categories that Corydalis Yanhusuo can interact with; the most serious is rated moderate. Theoretically, Corydalis yanhusuo might increase serum levels of drugs metabolized by CYP2C9.
Read the full interaction reportCorydalis Yanhusuo and Erdafitinib
These two interact in 2 distinct ways. Each one is explained separately below.
Why Are There 2 Interactions?
Corydalis Yanhusuo interacts with whole categories of medication. Erdafitinib falls into 2 of those categories, so it can interact with Corydalis Yanhusuo in 2 different ways. We’ve listed each one below — your overall risk is driven by the most serious of them (Moderate).
CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES
1 of 2Why this applies to Erdafitinib
Erdafitinib falls under CYTOCHROME P450 2C9 (CYP2C9) SUBSTRATES — the group Corydalis Yanhusuo interacts with.
Corydalis yanhusuo contains berberine. Preliminary clinical research shows that berberine can inhibit CYP2C9. Theoretically, Corydalis yanhusuo might also inhibit CYP2C9.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the gist for Balversa (erdafitinib). This cancer medicine is partly cleared by a liver enzyme called CYP2C9. Corydalis yanhusuo contains berberine, which early research suggests may slow that same enzyme down. If it does, your body could clear erdafitinib a little more slowly, meaning more of it builds up in your blood. That could mean stronger side effects, things like dry mouth, mouth sores, nail and skin changes, diarrhea, or vision changes from fluid behind the eye.
I want to be honest though: this is a theoretical concern based on lab work, not proven in people taking both together. Still, erdafitinib is a serious oncology drug, so please don't add corydalis without first checking with your oncology team or pharmacist.
- Guo, Y., Chen, Y., Tan, Z. R., Klaassen, C. D., and Zhou, H. H. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol 2012;68(2):213-217. PubMed
CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES
2 of 2Erdafitinib also falls under CYTOCHROME P450 3A4 (CYP3A4) SUBSTRATES.
Corydalis yanhusuo contains berberine. In vitro research and preliminary clinical research show that berberine moderately inhibits CYP3A4. Theoretically, Corydalis yanhusuo might also inhibit CYP3A4.
Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
Here's the gist with erdafitinib (Balversa): your body relies on a liver enzyme called CYP3A4 to help clear it. Corydalis contains berberine, which lab work and small human studies suggest can modestly slow that same enzyme down. If clearance slows, more erdafitinib can linger in your system, which could nudge up side effects like dry or sore mouth, changes in your nails or skin, eye problems (blurry vision, dry eyes), high phosphate levels, or diarrhea.
That said, this is a theoretical concern based on how these compounds behave, not proven harm in people taking them together. Still, erdafitinib is a serious cancer medicine with careful dosing, so please loop in your oncology team or pharmacist before adding Corydalis rather than starting or stopping anything on your own.
- Wu X, Li Q, Xin H, Yu A, Zhong M. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Eur J Clin Pharmacol 2005;61:567-72. PubMed
- Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000;7:273-82. PubMed
- Guo, Y., Chen, Y., Tan, Z. R., Klaassen, C. D., and Zhou, H. H. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol 2012;68(2):213-217. PubMed
- Hermann, R. and von, Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactions. Planta Med 2012;78(13):1458-1477. PubMed
What These Ratings Mean
Every interaction above is graded three ways — here’s the key to each label.
Clinically significant. Avoid the combination, or use only under close professional supervision.
Usually worth avoiding or managing — may need monitoring, a dose change, or timing apart.
Generally not serious. Be aware of it and mention it to your pharmacist.
- LikelyWell-controlled human studies have demonstrated the likely existence of this interaction.
- ProbableInteraction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists.
- UnlikelyInteraction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
- AHigh-quality meta-analysis (quantitative systematic review).
- BCase-control study.
- CConsensus.
- DAnecdotal evidence.
These ratings are for information only. Never start, stop, or otherwise change your therapy before speaking with your provider.
Corydalis Yanhusuo Also Interacts With Other Medications
Corydalis Yanhusuo has 1,159 moderate known drug interactions in our database — the Erdafitinib one above is among them. If you take anything else, check it against the full list below.
Check Another of Your Medications Against Corydalis Yanhusuo
We haven’t checked that one against Corydalis Yanhusuo yet — ask our pharmacists directly.
Covers the 2,830 medications we’ve checked against Corydalis Yanhusuo. Pick one to open its full report.
See Every Supplement That Interacts With Erdafitinib
This page covers Corydalis Yanhusuo only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Erdafitinib page lists 169 supplements it has a documented interaction with, worst first, each one explained.
The most serious there right now: Activated Charcoal (major), Grapefruit (major), Phosphate Salts (major), St. John's Wort (major) and Acacia Rigidula (moderate).
By severity: 4 major · 127 moderate · 38 minor.
From our pharmacist’s overview on the Erdafitinib page
“Erdafitinib (Balversa) treats bladder cancers driven by FGFR gene changes, and its benefit depends on holding a steady drug level, so this is a list to be genuinely careful with. Four entries are rated major.”
Reviewed by 2 · Jul 18, 2026
Where Corydalis Yanhusuo and Erdafitinib Sit Against Everything Else
Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.
#653 of 1,452 supplements looked up here in the last 7 days
#2,158 of 2,830 medications looked up here in the last 7 days
Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.
About Corydalis Yanhusuo
What is Corydalis Yanhusuo?
- Pain relief
- Menstrual cramps
- Headache
- Stress and sleep support
- Stomach and abdominal discomfort
Corydalis yanhusuo is a traditional Chinese herb used mainly for pain. Some early laboratory and animal research suggests its compounds may affect pain and the nervous system, but high-quality human studies are limited, so its true benefits and long-term safety are not well established. Talk with your pharmacist or doctor before using it, and avoid it during pregnancy and breastfeeding.
About Erdafitinib
What Is Erdafitinib Used For?
Brand name: Balversa
Balversa (erdafitinib) is used to treat adults with locally advanced or metastatic urothelial carcinoma (UC) — cancer of the bladder or urinary tract — that has spread and has not responded to, or has gotten worse after, at least one prior round of systemic treatment. Patients must have a specific type of FGFR3 genetic alteration in their tumor, confirmed by an FDA-approved test before starting.
Balversa is not recommended for patients who are eligible for — but have not yet received — a PD-1 or PD-L1 inhibitor (a type of immunotherapy). Those therapies should be tried first when appropriate.
Other Drugs & Corydalis Yanhusuo
Browse every other medication we’ve checked against Corydalis Yanhusuo — both the ones with a known interaction and the ones without. Select any drug for the full detail.
No drugs match “”.
1,159 interactions
- Diclofenac Sodium ›
- Diltiazem ›
- Nifedipine ›
- Ibuprofen ›
- Diphenhydramine ›
- Aspirin ›
- Hydrocortisone ›
- Insulin (rdna) ›
- Naproxen ›
- Erythromycin ›
- Estradiol ›
- Minocycline ›
- Propranolol ›
- Lidocaine ›
- Guaifenesin ›
- Hydrochlorothiazide ›
- Norethindrone ›
- Testosterone ›
- Verapamil ›
- Levonorgestrel ›
- Prednisone ›
- Quinidine ›
- Cyclosporine ›
- Dexamethasone ›
- Flurazepam ›
- Glyburide ›
- Insulin (pork) ›
- Triazolam ›
- Zopiclone ›
- Colchicine ›
- Fentanyl ›
- Flurbiprofen ›
- Oxybutynin ›
- Oxycodone ›
- Phenytoin ›
- Prednisolone ›
- Tacrolimus ›
- Temazepam ›
- Budesonide ›
- Carbamazepine ›
- Clindamycin ›
- Dextromethorphan ›
- Diclofenac Potassium ›
- Dipyridamole ›
- Doxorubicin ›
- Fluticasone ›
- Formoterol ›
- Hydralazine ›
- Indomethacin ›
- Insulin (human) ›
- Miconazole ›
- Morphine Sulfate ›
- Nitrazepam ›
- Trimipramine ›
- Amphetamine ›
- Buprenorphine ›
- Conjugated Estrogens ›
- Diazepam ›
- Everolimus ›
- Ivabradine ›
Showing 60 of 1,159 moderate interactions — see all 1,159 on the Corydalis Yanhusuo page.
No interaction 1,670 drugs checked — show the list
We also checked Corydalis Yanhusuo against these medications and found no known interaction in our sources. Open any page to confirm.
- Levothyroxine ›
- Methylphenidate ›
- Ivermectin ›
- Rosuvastatin ›
- Acetaminophen ›
- Escitalopram ›
- Docusate ›
- Valacyclovir ›
- Hydroxyurea ›
- Sumatriptan ›
- Amoxicillin ›
- Bupropion ›
- Methotrexate ›
- Bendamustine ›
- Acyclovir ›
- Doxycycline ›
- Isotretinoin ›
- Azithromycin ›
- Methylene Blue ›
- Ciprofloxacin ›
- Levothyroxine, Liothyronine ›
- Cephalexin ›
- Cyclopentolate ›
- Roxithromycin ›
- Pegunigalsidase Alfa-iwxj ›
- Ezetimibe ›
- Amoxicillin, Clavulanate Potassium ›
- Levothyroxine Sodium ›
- Dexmethylphenidate ›
- Daptomycin ›
- Mitomycin ›
- Thyroid Hormone ›
- Hexobarbitone ›
- Carbidopa, Levodopa ›
- Factor 7a ›
- Levodopa ›
- Hethylphenidate Hcl ›
- Lenvatinib ›
- Cefaclor ›
- Azelaic Acid ›
- Phenylephrine ›
- Hydroxychloroquine ›
- Pizotifen ›
- Bentoquatam ›
- Vancomycin ›
- Dirithromycin ›
- Digoxin ›
- Ribavirin Aerosol ›
- Triptorelin ›
- Alglucosidase Alpha ›
- Ropinirole ›
- Dextrothyroxine ›
- Rocuronium ›
- Tocainide ›
- Procainamide ›
- Salbutamol Sulfate ›
- Paracetamol ›
- Mitomycin C ›
- Flutemetamol F-18 ›
- Chenodiol ›
Showing the 60 most looked-up of 1,670 medications checked with no known interaction — see the full Corydalis Yanhusuo list.
Sources & How We Checked
Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference for vitamins, herbs and supplements — the basis for our interaction data.
- MedlinePlus, U.S. National Library of Medicine — NIH consumer drug information, used for the medication overviews.
- NIH Dietary Supplement Label Database (DSLD) — Official supplement product labels.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Taking Corydalis Yanhusuo and Erdafitinib Together: Common Questions
Can you take Corydalis Yanhusuo with Erdafitinib?
Why are there 2 interactions listed for Corydalis Yanhusuo and Erdafitinib?
How serious is the Corydalis Yanhusuo and Erdafitinib interaction?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Still Have a Question About Erdafitinib and Corydalis Yanhusuo?
Our pharmacists answer your medication & supplement questions — free.
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.